Dec 14, 2021 / 03:00PM GMT
Operator
Good day, and welcome to the Synthetic Biologics Business Update Call. (Operator Instructions) Please note this event is being recorded.
I'd now like to turn the conference over to Vincent Perrone, Director of Corporate Communication at Synthetic Biologics. Please go ahead.
Vincent I. Perrone - Synthetic Biologics, Inc. - Director of Corporate Communication
Thank you, Jason, and good morning, everyone. Welcome to Synthetic Biologics business update conference call to discuss the planned acquisition of VCN Biosciences. Today, I'm joined by Steven Shallcross, Chief Executive and Chief Financial Officer; and Dr. Vince Wacher, Head of Product and Corporate Development.
From the VCN team, we're joined by Manel Cascalló, PhD, Chief Executive Officer of VCN; and Frank Tufaro, PhD, Chief Operating Officer of VCN. Synthetic Biologics issued a press release this afternoon, which provided an overview of the planned acquisition, this release can be found on the Investor Relations section of our website at
Synthetic Biologics Inc Operational Update Call Transcript
Feb 15, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers